RECRUITING

Improving Stroke Motor Control With Non-invasive Brain Stimulation and Functional Electrical Stimulation

Description

This pilot study for stroke patients with chronic upper limb hemiplegia will examine the effects of non-invasive brain stimulation and neuromuscular electrical stimulation on hand motor control and corticospinal excitability. Specifically, this study will investigate the effects of timing and delivery of tDCS in conjunction with contralaterally controlled functional electrical stimulation.

Study Overview

Study Details

Study overview

This pilot study for stroke patients with chronic upper limb hemiplegia will examine the effects of non-invasive brain stimulation and neuromuscular electrical stimulation on hand motor control and corticospinal excitability. Specifically, this study will investigate the effects of timing and delivery of tDCS in conjunction with contralaterally controlled functional electrical stimulation.

Contralaterally Controlled FES Plus Transcranial Direct Current Stimulation for Hand Motor Control After Stroke: A Pilot Study

Improving Stroke Motor Control With Non-invasive Brain Stimulation and Functional Electrical Stimulation

Condition
Stroke
Intervention / Treatment

-

Contacts and Locations

Cleveland

MetroHealth Medical Center, Cleveland, Ohio, United States, 44109

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Age ≥ 21
  • 2. ≥ 6 months since first clinical hemorrhagic or nonhemorrhagic stroke
  • 3. Able to follow 3-stage commands and remember 2 of 3 items after 30 minutes
  • 4. Full volitional elbow extension/flexion and hand opening/closing of unaffected limb
  • 5. Adequate active movement of shoulder and elbow to position the paretic hand in the workspace for table-top task practice
  • 6. Patient must be able to sit unassisted in an armless straight-back chair for the duration of the screening portion of the eligibility assessment
  • 7. Medically stable
  • 8. ≥ 10° finger extension
  • 9. Unilateral upper limb hemiparesis with finger extensor strength of ≤ grade 4/5 on the manual muscle test AND a score of
  • 10. Skin intact on hemiparetic arm, hand and scalp
  • 11. While relaxed, surface neuromuscular electrical stimulation of finger extensors and thumb extensors and/or abductors produces a functional degree of hand opening without pain.
  • 12. No significant visual or hearing impairment
  • 1. Co-existing neurological condition other than prior stroke involving the hemiparetic upper limb (e.g., peripheral nerve injury, Parkinson's disease, spinal cord injury, traumatic brain injury, multiple sclerosis).
  • 2. Uncontrolled seizure disorder
  • 3. Use of seizure lowering threshold medications at the discretion of the study physician (Dr. Rich Wilson)
  • 4. Cardiac pacemaker or other implanted electronic device and/or stent
  • 5. Pregnant
  • 6. Intramuscular botox injections in any upper extremity muscle in the last 3 months
  • 7. Insensate arm, forearm, or hand
  • 8. Severely impaired cognition and communication
  • 9. Uncompensated hemi-neglect (extinguishing to double simultaneous stimulation)
  • 10. Severe shoulder or hand pain (unable to position hand in the workspace without pain)
  • 11. Metal implant in the head

Ages Eligible for Study

21 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

MetroHealth Medical Center,

David A Cunningham, PhD, PRINCIPAL_INVESTIGATOR, MetroHealth Medical Center

Study Record Dates

2026-08-01